Measurement for autonomic function

What is this patent about?

’045 is related to the field of medical diagnostics and physiological monitoring, specifically focusing on the objective detection and quantification of pain and nociception. Traditionally, pain assessment has relied on subjective self-reporting, which is unreliable in non-verbal patients, children, or animals. The invention addresses this by monitoring the autonomic nervous system (ANS) through skin potential measurements, providing a measurable correlate for the physiological stress responses associated with moderate to severe pain.

The underlying idea behind ’045 is that persistent pain triggers a specific autonomic response—mediated by the right cardiac vagal nerve—which creates a measurable electrical asymmetry between the left and right sides of the body. By measuring the naturally occurring voltage difference between contralateral skin sites, the system can detect the dominance of parasympathetic tone over sympathetic tone. The key engineering insight is that these physiological signals are extremely weak, often smaller than the inherent electrical noise or offset potential generated by standard medical electrodes, requiring a specialized hardware approach to ensure signal integrity.

The claims of ’045 focus on a diagnostic system and method utilizing at least two self-adhesive sensors that are precisely matched to maintain a paired offset potential of less than +/- 0.01 mV. These sensors are coated with a conductive material, preferably silver-chloride (AgCl), and are connected to a data gathering device designed to measure the minute voltage differences caused by the interplay of sympathetic and parasympathetic nerve activations. The independent claims specifically protect the use of these ultra-low-offset sensors to quantify nociception by measuring the potential difference across a load resistor.

In practice, the invention works by placing the matched sensors on identical contralateral sites, such as the centers of the palms or opposite sides of the neck, and recording the voltage trace for several minutes. A negative voltage reading—where the right side of the body shows a lower potential than the left—serves as an objective indicator of moderate to severe pain. The system utilizes a load resistor (typically 22 k Ohms) to produce a voltage drop that can be interpreted by a digital data logger or strip chart recorder, allowing clinicians to visualize pain relief or distress in real-time.

This approach differentiates itself from prior art like Galvanic Skin Response (GSR) by being entirely passive; it does not inject an external current into the subject to measure resistance. Unlike previous attempts that used high-offset aluminum or cup-style electrodes, this invention employs pre-applied conductive gel and matched AgCl coatings to eliminate electrochemical artifacts that would otherwise swamp the signal. By achieving a stable, near-zero baseline through ultra-low offset matching, the device provides a consistent and repeatable metric for autonomic shifts that subjective scales and high-noise sensors cannot provide.